| Chr | NA |
| start | NA |
| end | NA |
| lncRNA name | lncRNA00544 |
| entrez id | NA |
| hgnc id | NA |
| ensg id | NA |
| refseq id | NA |
| methods | Microarray, qPCR |
| regulated | up-regulated |
| function description | Here, we aim to identify the lncRNAs which are involved in the particular type luminal BC progression. By Gene Chips analysis, we found a novel lncRNA00544, which was highly expressed in the metastatic axillary nodes compared with corresponding luminal BC tissues (fold change=2.26, P=0.043).Many differentially expressed lncRNAs including circulating lncRNA and lncRNA signatures |
| pubmed id | 28959047 |
| year | 2017 |
| title | Long non-coding RNA00544 serves as a potential novel predictive and prognostic marker for HR+HER2 subtype breast cancer |
| drug | X |
| circulating | V |
| survival | V |
CopyRight © University of Miami, USA; Harbin Medical University, China